Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis

Affiliations

• ¹ Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. RKanagal@mdanderson.org.
• ² Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
• ³ Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
• ⁴ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
• ⁵ Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, United States.
• ⁶ Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.